10.07.2015 Views

traditional knowledge conference 2008 te tatau pounamu

traditional knowledge conference 2008 te tatau pounamu

traditional knowledge conference 2008 te tatau pounamu

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Over this time the aquaculture industry in New Zealand has grown from reasonably small si<strong>te</strong>s inthe Marlborough Sounds, Northland and the Coromandel Peninsula to one of the fas<strong>te</strong>st growingcomponents of the New Zealand seafood industry. According to the Chief Executive of Ngāi TahuSeafood, this development has been too fast; there are now too many ventures growing green-shellmussels here in New Zealand and in places like Chile and South Australia, which makes it an extremelycompetitive and increasingly unprofitable market (Keene, 2007). In a competitive global market theindustry is looking to produce high-quality food as well as high-value products for the pharmaceuticaland neutricutical industries. A number of native species have been identified as possessing chemicalsthat have anti-cancer and other pharmaceutical benefits. To da<strong>te</strong>, the emphasis on research foraquaculture has been the development of commercially viable products. Early in <strong>2008</strong>, AquacultureNew Zealand (<strong>2008</strong>) put out its most recent draft research stra<strong>te</strong>gy with a focus on the four backbonesof growth: security, sustainability, efficiency and innovation. This research stra<strong>te</strong>gy is in turn manda<strong>te</strong>dwithin the Aquaculture Stra<strong>te</strong>gy.In the second half of <strong>2008</strong>, the Ministry of Fisheries is also consulting on the Māori CommercialAquaculture Settlement plan (Ministry of Fisheries, <strong>2008</strong>). The plan sets out details about how theCrown in<strong>te</strong>nds to comply with its pre-commencement space obligations to iwi by the end of 2014 andincludes the possibility of: space allocation, the purchase of existing aquaculture farms or payouts of thefinancial equivalent of the Crown’s settlement obligation. The consultation will allow iwi to expresstheir views on the plan at a time when many are also considering their options for en<strong>te</strong>ring intoaquaculture endeavours.Bio<strong>te</strong>chnology and AquacultureMost New Zealand aquaculture currently focuses on mussels, salmon and oys<strong>te</strong>rs. To accelera<strong>te</strong> growththe aquaculture industry is diversifying into new species and new products. This has fuelled in<strong>te</strong>rest innew bio<strong>te</strong>chnologies such as biopharming and genetic engineering, which may have applications for theaquaculture industry (FAO, 2006). Modern bio<strong>te</strong>chnological advancement has wide applications forhuman activities that ex<strong>te</strong>nd from the production of food to the management of diseases. A definition ofbio<strong>te</strong>chnology includes “the application of scientific and engineering principles to the processing ofma<strong>te</strong>rial by biological agents, and the processing of biological ma<strong>te</strong>rials to improve the quality of life,by isolating, modifying and synthesising the genetic instructions responsible for actual biologicalprocesses” (Statistics NZ, 2001). In the last 50 years we have seen rapid growth in <strong>te</strong>chnologicaladvancement, especially in bio<strong>te</strong>chnology and genetic engineering. The impact of these new<strong>te</strong>chnologies, however, causes concern to many. There has been a call to bet<strong>te</strong>r align new <strong>te</strong>chnologicaladvancements with societal values. This involves communities that may be affec<strong>te</strong>d by new<strong>te</strong>chnological advancements being bet<strong>te</strong>r informed and having their concerns ac<strong>knowledge</strong>d byscientists and corporations (Cram, 2005; Royal Commission on Genetic Modification, 2001).Biopharming is when crops, plants or livestock are farmed to produce neutricuticals (or foodsupplements), and/or genetically engineered so that they produce pharmaceutical (or medicinal)substances that they would not have produced in their natural sta<strong>te</strong>. A New Zealand example ofbiopharming is the sea sponge, Mycale hentscheli, from Pelorus Sound, that has been found to havecancer fighting properties (peloruside A.) and has po<strong>te</strong>ntial within the billion-dollar pharmaceuticalindustry (Handley, Page & Northco<strong>te</strong>, 2006). Our in<strong>te</strong>rest in biopharming—and the po<strong>te</strong>ntial threat oropportunity it poses for Māori aquaculture business in<strong>te</strong>rests and aspirations qui<strong>te</strong> apart from Māorikaitiakitanga responsibilities—lies in the role it might play in Māori decision making. This in<strong>te</strong>restfollows on from our initial in<strong>te</strong>rest in genetic <strong>te</strong>sting and its impact on Māori health decisions. Boththese research projects are introduced next, before we return to aquaculture and five themes that havearisen in our research so far.The Current Research ProgrammeThe present research is the second project in a Foundation for Research Science and Technology(FRST)-funded programme of research that examines Māori decision-making processes and thepo<strong>te</strong>ntial impact of new <strong>te</strong>chnologies on the decision-making processes themselves as well as thedecisions that are made. The first project examined Māori decision making about new <strong>te</strong>chnologies in150

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!